BALCHEM CORP·4

Dec 5, 4:23 PM ET

van Gunsteren Job Leonard 4

4 · BALCHEM CORP · Filed Dec 5, 2025

Insider Transaction Report

Form 4
Period: 2025-12-04
van Gunsteren Job Leonard
SVP and GM, Specialty Products
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2025-12-04$60.85/sh+6,000$365,10015,446 total
  • Sale

    Common Stock

    [F2]
    2025-12-04$153.07/sh4,235$648,25911,211 total
  • Sale

    Common Stock

    [F3]
    2025-12-04$153.80/sh1,765$271,4649,446 total
  • Exercise/Conversion

    Stock Option

    [F4]
    2025-12-04+6,0000 total
    Exercise: $60.85Exp: 2026-02-23Common Stock (6,000 underlying)
Footnotes (4)
  • [F1]Exercise of fully vested non-qualified stock options.
  • [F2]This transaction was executed in multiple sales ranging from $152.6500 to $153.6100 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  • [F3]This transaction was executed in multiple sales ranging from $153.6900 to $154.0600 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  • [F4]Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.
Signature
/s/ Travis Larsen, Attorney in Fact for Job Leonard van Gunsteren|2025-12-05

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4